MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, B. R.
Right arrow Articles by Clark, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, B. R.
Right arrow Articles by Clark, R. B.

Vol. 58, Issue 2, 421-430, August 2000

Kinetic Analysis of Agonist-Induced Down-Regulation of the beta 2-Adrenergic Receptor in BEAS-2B Cells Reveals High- and Low-Affinity Components

Bruce R. Williams, Roger Barber, and Richard B. Clark

Department of Integrative Biology and Pharmacology, The University of Texas Medical School, Houston, Texas

We examined the interrelationships of internalization and down-regulation of the beta 2-adrenergic receptor in response to treatment of the BEAS-2B human epithelial cell line with both a series of agonists at high occupancy and with various concentrations of fenoterol that gave occupancies from 0.93 to 0.001. We found that the extent of internalization measured after a 30-min treatment increased as a function of coupling efficiency, with ephedrine, dobutamine, albuterol, fenoterol, and epinephrine giving 0, 7, 17, 48, and 55% internalization, respectively. With the exception of dobutamine, the rates of down-regulation (kdeg) also showed a dependence on agonist coupling efficiency, giving (in terms of fraction of receptors lost/h) 0.082 with ephedrine, 0.250 with dobutamine, 0.148 with albuterol, 0.194 with fenoterol, and 0.212 with epinephrine. Comparison of down-regulation to internalization showed that weak agonists caused down-regulation in the absence of significant internalization. The extent of internalization caused by fenoterol over a 1000-fold range of occupancy was proportional to agonist occupancy. However, although no internalization was observed with the low concentrations (0.2 and 2 nM fenoterol), these concentrations did cause significant down-regulation. Thus, as with partial agonists, it was clear that down-regulation occurred in the absence of measurable internalization. The kinetics of agonist-induced down-regulation are consistent with a scheme in which down-regulation proceeds by two pathways; a high-affinity, low-capacity component (EC50 = 0.5 nM) clearly dissociated from internalization and a low-affinity, high-capacity component (EC50 = 160 nM) closely correlated with internalization.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark
Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. M. Tran, J. Friedman, E. Qunaibi, F. Baameur, R. H. Moore, and R. B. Clark
Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the {beta}2-Adrenergic Receptor Using Phosphoserine-Specific Antibodies
Mol. Pharmacol., January 1, 2004; 65(1): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Liang, S. Austin, Q. Hoang, and P. H. Fishman
Resistance of the Human {beta}1-Adrenergic Receptor to Agonist-mediated Down-regulation: ROLE OF THE C TERMINUS IN DETERMINING {beta}-SUBTYPE DEGRADATION
J. Biol. Chem., October 10, 2003; 278(41): 39773 - 39781.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics